Geoffrey Rose
Fortuna: 595 024 $ al 30/06/2026
Fortuna: 595 024 $ al 30/06/2026
Geoffrey Beran Rose is Chief Commercial Officer at Pulmonx Corp.
since 2020.
Formerly, Mr. Rose was Group Director-Global Marketing at Boston Scientific Corp.
from 2013 to 2014.
Mr. Rose completed undergraduate studies at Yale University and earned an MBA from MIT Sloan School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PULMONX CORP. 1,08 % | 01/06/2026 | 457.711 ( 1,08 % ) | 595 024 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PULMONX CORPORATION | Corporate Officer/Principal | 01/01/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Ventas & Marketing | 01/12/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Pulmonx Corp.
Pulmonx Corp. Medical SpecialtiesHealth Technology Develops and manufactures zephyr endobronchial valves for the treatment of emphysema | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.